It is a financial services public limited company based in Mumbai, Maharashtra, India, established in 1995.
1995 | Mumbai, Maharashtra, India | ActiveRelic Pharma Limited, a active public limited company, was established on 04 May 1995 in Mumbai, Maharashtra, India. Engaging in brokerage & trading services within the financial and insurance service sector, it holds CIN: U67120MH1995PLC088000. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.25 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Its leadership includes Hemant Kantilal Choksey (Director), Baijoo Madhusudan Raval (Director), Uday Madhusudan Raval (Director). Past directors included Hemant Kantilal Choksey, Madhusudan Mohanlal Raval, Narendra Ishwarlal Gandhi. Its latest AGM occurred on 19 August 2024, with the balance sheet filed on 31 March 2024. It is based at J-Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, 400002.
U67120MH1995PLC088000
088000
04 May 1995
₹3.25 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Relic Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemant Kantilal Choksey | Director | 19 Apr 2014 | Current |
| Baijoo Madhusudan Raval | Director | 04 May 1995 | Current |
| Uday Madhusudan Raval | Director | 04 May 1995 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 08 Apr 2014 | Past |
| Pramod Abcsdd | Director | 30 May 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Relic Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 189.29% decrease in profit. The company's net worth dipped by a decrease of 0.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Relic Pharma had a promoter holding of 99.93% and a public holding of 0.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Relic Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Relic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relic Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Relic Pharma Limited last Annual general meeting of members was held on 19 Aug 2024 as per latest MCA records. was recorded as a recent event.
Relic Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Hemant Kantilal Choksey was appointed as a Director was appointed as a Director on 19 Apr 2014 & has been associated with this company since 11 years 7 months . was completed.
The activity Baijoo Madhusudan Raval was appointed as a Director was appointed as a Director on 04 May 1995 & has been associated with this company since 30 years 7 months . was completed.
The activity Uday Madhusudan Raval was appointed as a Director was appointed as a Director on 04 May 1995 & has been associated with this company since 30 years 7 months . was completed.
Progress on Relic Pharma Limited was registered on 04 May 1995 with Roc Mumbai & aged 30 years 7 months as per MCA records. was documented.
The CIN of Relic Pharma Limited is U67120MH1995PLC088000.
Relic Pharma Limited is headquartered at J-Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, 400002.
Relic Pharma Limited was incorporated on 04 May 1995.
The current directors of Relic Pharma Limited are
The primary industry of Relic Pharma Limited is Financial And Insurance Service.
Relic Pharma Limited is unlisted.
The authorized capital of Relic Pharma Limited is ₹3.25 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Relic Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX